Mark Lappe
Amministratore Delegato presso INHIBRX, INC.
Patrimonio netto: 104 M $ in data 30/04/2024
Posizioni attive di Mark Lappe
Società | Posizione | Inizio | Fine |
---|---|---|---|
INHIBRX, INC. | Amministratore Delegato | 01/04/2010 | - |
Presidente | 01/04/2010 | - | |
Fondatore | 01/04/2010 | - | |
Presidente | 01/04/2020 | - | |
Direttore Finanziario/CFO | 01/04/2010 | 01/04/2020 | |
Efficacy Capital Ltd. | Corporate Officer/Principal | 10/06/2009 | - |
Storia della carriera di Mark Lappe
Precedenti posizioni note di Mark Lappe
Società | Posizione | Inizio | Fine |
---|---|---|---|
REPROS THERAPEUTICS INC | Presidente | 01/01/2008 | 12/11/2009 |
Osmetech Ltd.
Osmetech Ltd. Medical/Nursing ServicesHealth Services Osmetech Ltd. designs, develops, manufactures and sells molecular diagnostics instruments and consumables enabling deoxyribonucleic acid, ribonucleic acid and protein testing. Its operates in Atlanta, Boston and Pasadena in the US, serving the growth, near patient testing market targeting small to medium sized hospitals. Osmetech was founded in 1993 and is headquartered in London, the United Kingdom. | Direttore/Membro del Consiglio | 01/01/2009 | 28/08/2009 |
Efficacy Biotech Fund LP | Fondatore | - | - |
Corporate Officer/Principal | - | - | |
Inhibrx LP
Inhibrx LP BiotechnologyHealth Technology Inhibrx LP developed therapeutic antibodies and pharmaceuticals. Its programs focused on oncology, inflammatory and metabolic diseases and these programs are based on an implementation of multiple antibody and biologic development strategies for therapeutic lead generation, selection, functional enhancement, and optimization. The firm's platforms enabled fit-for-function biotherapeutics that interface with the biology of each target antigen, focus immune activation, and mediate enhanced signaling. The company was founded by Quinn Deveraux, Brendan Eckelman, and Mark Paul Lappe in 2010 and was headquartered in La Jolla, CA. | Amministratore Delegato | 01/01/2010 | - |
Fondatore | 01/01/2010 | - | |
Efficacy Capital LLC
Efficacy Capital LLC Investment ManagersFinance Founded in 2004 by Mark Paul Lappe and Jon Faiz Kayyem, Efficacy Capital LLC is a hedge fund manager located in La Jolla, California. The firm provides investment management services primarily to high net-worth individuals. They also manage pooled investment vehicles, including hedge funds and mutual funds | Direttore degli Investimenti | 03/11/2010 | - |
Fondatore | 03/11/2010 | - | |
Gestore di Portafoglio-Azioni | 03/11/2010 | - | |
Portfolio Manager-Fixed Income | 25/05/2012 | - | |
Lappe & Associates, Inc. | Fondatore | 19/07/2011 | - |
Corporate Officer/Principal | 10/06/2009 | 19/07/2011 |
Statistiche
Distribuzione geografica
Stati Uniti | 8 |
Regno Unito | 2 |
Posizioni
Founder | 5 |
Chairman | 3 |
Corporate Officer/Principal | 3 |
Settori
Health Technology | 4 |
Health Services | 2 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
INHIBRX, INC. | Health Technology |
Aziende private | 7 |
---|---|
Repros Therapeutics, Inc.
Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Repros Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the development of drugs to treat hormonal and reproductive systems disorders. Its products include Enclomiphene and Proellex. The company was founded on August 20, 1987 and is headquartered in The Woodlands, TX. | Health Technology |
Osmetech Ltd.
Osmetech Ltd. Medical/Nursing ServicesHealth Services Osmetech Ltd. designs, develops, manufactures and sells molecular diagnostics instruments and consumables enabling deoxyribonucleic acid, ribonucleic acid and protein testing. Its operates in Atlanta, Boston and Pasadena in the US, serving the growth, near patient testing market targeting small to medium sized hospitals. Osmetech was founded in 1993 and is headquartered in London, the United Kingdom. | Health Services |
Efficacy Capital Ltd. | |
Lappe & Associates, Inc. | |
Efficacy Capital LLC
Efficacy Capital LLC Investment ManagersFinance Founded in 2004 by Mark Paul Lappe and Jon Faiz Kayyem, Efficacy Capital LLC is a hedge fund manager located in La Jolla, California. The firm provides investment management services primarily to high net-worth individuals. They also manage pooled investment vehicles, including hedge funds and mutual funds | Finance |
Inhibrx LP
Inhibrx LP BiotechnologyHealth Technology Inhibrx LP developed therapeutic antibodies and pharmaceuticals. Its programs focused on oncology, inflammatory and metabolic diseases and these programs are based on an implementation of multiple antibody and biologic development strategies for therapeutic lead generation, selection, functional enhancement, and optimization. The firm's platforms enabled fit-for-function biotherapeutics that interface with the biology of each target antigen, focus immune activation, and mediate enhanced signaling. The company was founded by Quinn Deveraux, Brendan Eckelman, and Mark Paul Lappe in 2010 and was headquartered in La Jolla, CA. | Health Technology |
Efficacy Biotech Fund LP |
- Borsa valori
- Insiders
- Mark Lappe
- Esperienza